Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DR26F7F33
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,737
Award facts
- Contract value 100% obligated
- $44,737.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $44,737.11 delivery order to AmerisourceBergen Drug Corp on June 25, 2026, for SKYRIZI 150 MG/ML (risankizumab) pharmaceutical supply.
This is a firm fixed-price delivery order under the DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order has an ultimate completion date of June 26, 2026, reflecting a single-shipment pharmaceutical delivery typical of DLA transactional medical supply ordering. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F7F33?
SPE2DR26F7F33 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 25, 2026.
How much is contract SPE2DR26F7F33 worth?
The government has obligated $44,737 on SPE2DR26F7F33.
Is contract SPE2DR26F7F33 an order under another contract?
Yes. SPE2DR26F7F33 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F7F33 competed?
The extent of competition for SPE2DR26F7F33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award